Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
Plos One|December 24, 2008
Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patientsEva Gross, Birgit Busse, Matthias Riemenschneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular featuresRudolf Napieralski, Katja Ott, Markus Kremer, et al.
Oncotarget|October 6, 2017
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcomeThomas Kunzke, Benjamin Balluff, Annette Feuchtinger, et al.
Langenbeck'S Archives of Surgery|March 13, 2009
Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomasJan Friederichs, Claus W H von Weyhern, Robert Rosenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2009
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinomaGertraud Stocker, Katja Ott, Nils Henningsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDGAmbros J Beer, Sylvie Lorenzen, Stephan Metz, et al.
Cancers|May 13, 2026
Treatment Limitations and Missing Information in Peritoneal Metastatic Gastric CancerBeate Rau, Franziska Köhler, Annika Kurreck, et al.
ESMO Open|July 30, 2019
Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer FacultyFlorian Lordick, Radka Obermannova, Doris Vola, et al.
Frontiers in Oncology|February 22, 2020
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-StudyElizabeth Smyth, Maren Knödler, Anne Giraut, et al.
Abdominal Radiology (New York)|April 21, 2026
Prognostic value of abdominal aortic calcification in patients with esophageal cancer undergoing neoadjuvant therapy and esophagectomyJacob Jalil Hassan, Daniele Romeo, Stefan Niebisch, et al.
Pageof 33